Unum Group 6.250% Junior Subordinated Notes due 2058 (UNMA)

Unum Group reported Q2 2025 earnings of $2.07 per share, missing analyst estimates. Revenue grew to $3.36 billion, but the company experienced challenges in claims costs, customer retention, and new business sales across its insurance segments.

Five U.S. stocks have recently increased their dividends, with analysts seeing potential for price appreciation and attractive total return potential over the next 12 months.

Globe Life Inc.'s first-quarter 2025 net operating income missed estimates, but premiums and underwriting income improved. The company's results were impacted by lower investment income and higher expenses.

Unum is a strong dividend stock with a 2.68% dividend yield, which is higher than the industry and S&P 500 averages. The company has increased its dividend by an average of 7.59% annually over the last 5 years, and its payout ratio is low at 18%, indicating potential for future dividend growth.

The cancer insurance market is expected to grow strongly in the coming years, driven by factors such as rising cancer incidence rates, medical inflation, and heightened awareness. Key trends include innovative product developments, customizable policies, and integration with health plans. The increasing number of cancer cases is a major driver for the market's growth.